Valneva Reaffirms 2025 Outlook: Sales Revenue Projected At €170M-€180M, Total Revenue To Reach €180M-€190M; R&D Investments Of €90M-€100M
Benzinga
05-07
Financial OutlookThe Company confirms the following guidance on its future results:
Product sales expected to grow to €170-180 million in 2025, driving positive cash-flows for the overall commercial business
Total revenues expected to reach €180-190 million in 2025
Total R&D investments expected between €90 - €100 million in 2025, which will be partially offset by grant fundings and anticipated R&D tax credits
Continued stringent focus on cash management supporting sufficient cash runway to reach key inflection points; targeting more than 50% lower operating cash burn in 2025